热门资讯> 正文
加州太平洋生物科学公司任命首席财务官
2025-03-27 21:11
- Sequencing solutions provider Pacific Biosciences of California (NASDAQ:PACB) announced on Thursday the appointment of Jim Gibson to the post of CFO, effective March 31.
- Gibson joins from Sequoia, a strategic compensation and benefits solutions provider.
- Shares were +0.79% pre-market to $1.28.
More on Pacific Biosciences of California
- Pacific Biosciences: Uncertain Federal Research Funding Latest Blow For Already-Battered Stock
- Pacific Biosciences of California, Inc. 2024 Q4 - Results - Earnings Call Presentation
- Pacific Biosciences of California, Inc. (PACB) Q4 2024 Earnings Call Transcript
- PacBio outlines 2025 revenue guidance of $155M-$170M amid new product launches
- Pacific Biosciences of California Non-GAAP EPS of -$0.20 misses by $0.03, revenue of $39.2M misses by $1.48M
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
